400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2022-06-15
精准肠道微生物组研发商
医疗信息化
医药数据库
Seeds Capital;
Seeds Capital;
Pruksa;
Pruksa;
TVM Capital Healthcare;
Pureland Group Venture;
GK Goh;
Vulcan Capital;
Emtek;
Blue7
2021-12-16
神经退行性疾病疗法开发商
医药研发/制造
AI+制药
Section 32;
Section 32;
ALS Investment Fund;
ALS Investment Fund;
Threshold Ventures;
LifeForce Capital;
BlackRock;
Tao Capital Partners;
Vulcan Capital;
Eli Lilly;
Merck GHI Fund
2021-07-28
临床管理平台提供商
AI+辅助诊断
医疗信息化
Washington Research Foundation;
Washington Research Foundation;
Alumni Ventures;
Alumni Ventures;
Vulcan Capital;
Founders' Co-op;
Arnold Venture Group
2020-11-19
远程治疗平台
医疗服务
远程医疗
2020-09-11
健康保险服务提供商
健康管理
健康咨询
Necessary Ventures;
Necessary Ventures;
Sure Ventures;
Sure Ventures;
Work Life;
AMV;
Future Positive Capital;
Digital Currency Group;
AirAngels;
Santander;
QED Investors;
Core Innovation Capital;
Precursor Ventures;
Foundation Capital;
Vulcan Capital;
Unpopular Ventures;
Healthy Ventures;
Maverick Capital;
Meridian Street Capital
2020-05-27
医疗数据分析、可视化和AI服务提供商
综合服务
软件服务
Washington Research Foundation;
Washington Research Foundation;
Founders'Co-op;
Founders'Co-op;
The Arnold Group;
Vulcan Capital
2020-05-25
临床管理平台提供商
AI+辅助诊断
医疗信息化
Founders' Co-op;
Founders' Co-op;
Arnold Venture Group;
Arnold Venture Group;
Vulcan Capital;
Washington Research Foundation
2020-04-09
医院信息系统研发商
AI+辅助诊断
医疗信息化
Valley Capital Partners;
Valley Capital Partners;
Blumberg Capital;
Blumberg Capital;
金沙江资本;
Vulcan Capital
2020-01-15
医疗即时报销平台运营商
医疗信息化
药品信息化
500 Startups;
500 Startups;
Susa Capital;
Susa Capital;
Hustle Fund;
Village Global;
Great Oaks Venture Capital;
Vulcan Capital;
Social Starts L.P.;
CoFound Partners
2018-05-31
一家临床阶段的制药公司
医药研发/制造
化学&生物药
辉瑞;
辉瑞;
Sequoia Capital;
Sequoia Capital;
Epiq Capital;
Verily;
杜比创投;
Lamond Family;
Breakout Ventures;
Takeda Ventures;
Vulcan Capital;
Huizenga Capital Management
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10